Skip To Main Content
K. Angelou on Muck Rack

K. Angelou

As seen in: European Journal of Obstetrics & Gynaecology and Reproductive Biology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to K. Angelou’s profile

Articles by K. Angelou

|
By V. Pergialiotis, K. Angelou, D. G. Vlachos, C. Theofanakis, V. Theodoulidis, N. Thomakos, A. Rodolakis, D. Haidopoulos
| European Journal of Obstetrics & Gynaecology and Reproductive Biology Verified
V. Pergialiotis K. Angelou D. Vlachos C. Theofanakis V. Theodoulidis N. Thomakos A. Rodolakis D. Haidopoulos Introduction and aims of the study: Pelvic exenteration is an ultraradical surgical procedure that is performed in patients with pelvic malignancies that are either refractory to primary treatment or for palliative purposes.
Open in Who Shared Issue with article?

570 Severe fetomaternal hemorrhage. a report of eight cases

|
By E. Tsianaka, A. Charitou, K. Angelou, M. Diakosavvas
| European Journal of Obstetrics & Gynaecology and Reproductive Biology Verified
This paper is only available as a PDF. To read, Please Download here. Abstract Background Fetomaternal hemorrhage (FMH) is a poorly understood condition in which involves fetal blood loss into the maternal circulation of more than 150ml or more than half fetal blood volume. Massive fetomaternal hemorrhage (>150 ml) occurs in 0.12 to 0.5% of pregnancies. Very small amount of fetal red cells are normally detectable in all pregnancies.
Open in Who Shared Issue with article?
|
By V. Pergialiotis, K. Angelou, D. G. Vlachos, C. Theofanakis, N. Thomakos, A. Rodolakis, D. Haidopoulos, V. Theodoulidis
| European Journal of Obstetrics & Gynaecology and Reproductive Biology Verified
Introduction and aims of the study: Pelvic exenteration is an ultraradical surgical procedure that has been used as salvage therapy for patients with advanced gynecologic malignancy. As a procedure it is accompanied by significant rates of complications that may affect up to one half of patients.
Open in Who Shared Issue with article?
|
By E. Tsianaka, A. Charitou, A. Alexaki, G. Kandili, A. Charitou, A. Alexaki, G. Kandili, K. Angelou, M. Diakosavvas, A. Kontogianni, A. Vallindra
| European Journal of Obstetrics & Gynaecology and Reproductive Biology Verified
E. Tsianaka A. Charitou A. Alexaki G. Kandili K. Angelou M. Diakosavvas A. Kontogianni A. Vallindra Abstract Background Less invasive surfactant application (LISA) is widely and increasingly used in Europe for the treatment of respiratory distress syndrome in preterm infants. There is a growing body of evidence that LISA‐treated infants are at a decreased risk for bronchopulmonary dysplasia compared to intubation and mechanical ventilation and other non‐invasive strategies of respiratory support.
Open in Who Shared Issue with article?
Show More